10 November 2014 - Deborah Wilkes
Archived
Bayer has completed the acquisition of China's Dihon Pharmaceutical for CNY3.6 billion (US$588 million). The German company said it now had "the leading position in the OTC industry in China".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.